NCT06107725View on ClinicalTrials.gov

Maimonides Minocycline in Stroke Study

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

1,120

Participants

Timeline

Start Date

November 1, 2023

Primary Completion Date

November 1, 2025

Study Completion Date

February 1, 2026

Conditions
Stroke, AcuteIschemic StrokeHemorrhagic StrokeMortalityMorbidity
Interventions
DRUG

Minocycline

Minocycline 200 mg every 24 hours for five days to be initiated within 24hr of stroke onset.

Trial Locations (1)

11219

RECRUITING

Maimonides Medical Center, Brooklyn

Sponsors
All Listed Sponsors
lead

Maimonides Medical Center

OTHER